Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Docetaxel Polymeric Micelle (PM) in Recurrent or Metastatic HNSCC [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the efficacy and safety of a polymeric micelle formulation of docetaxel in recurrent or metastatic head and neck squamous…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Docetaxel Polymeric Micelle (PM) (docetaxel)

Snippet

Sponsor: Samyang Biopharmaceuticals Corporation | Conditions: Head and Neck Squamous Cell Carcinoma | Phase 2 | Status: UNKNOWN